INVIBIO Ltd | Date: 2015-02-17
An IM nail is positioned within a medullary canal and secured in position by bone screws. The nail includes bores which engage insert assemblies and engage the screws. Each insert assembly is in two parts. Part includes a head and a narrower neck; and similarly, part includes a head and a narrower neck. A bore extends through the assembly from one side to the other. Part of the assembly is engaged with a nail by insertion into the nail via mouth; and part is engaged with the nail by insertion into the nail via mouth. When in position the parts abut one another and define bore which can receive screws. The nail is made from a polyetheretherketone (PEEK)/carbon fibre composite. Parts of the insert assemblies are produced separately from the nail. They may be produced by injection moulding a polymeric composition comprising PEEK and barium sulphate.
News Article | April 28, 2017
— Global New Medical Materials and Biomaterials Industry Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Companies profiled in this report are Invibio, Str, Avitus, Sagemax, Stratasys, Formlab, Terapore Technologies, Nanoh2o (Lg), Secant Medical, Covalent-Coating, Nasseo, Tribofilm, Acs Material, Palmaz Scientific in terms of Basic Information, Manufacturing Base, Sales Area and Its Competitors, Sales, Revenue, Price and Gross Margin (2012-2017). Split by Product Types, with sales, revenue, price, market share of each type, can be divided into • Medical polymers • Bioceramics • Medical 3D Printing Materials • Membranes • Surface Modifications • Other Split by applications, this report focuses on sales, market share and growth rate of New Medical Materials and Biomaterials in each application, can be divided into • Packaging • Transplant components • Dental products • Catheters • Other Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/488452 Table of Content: 1 New Medical Materials and Biomaterials Market Overview 2 Global New Medical Materials and Biomaterials Sales, Revenue (Value) and Market Share by Manufacturers 3 Global New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 4 Global New Medical Materials and Biomaterials Manufacturers Profiles/Analysis 5 North America New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 6 Latin America New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 7 Europe New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 8 Asia-Pacific New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 9 Middle East and Africa New Medical Materials and Biomaterials Sales, Revenue (Value) by Countries, Type and Application (2012-2017) 10 New Medical Materials and Biomaterials Manufacturing Cost Analysis 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 13 Market Effect Factors Analysis 14 Global New Medical Materials and Biomaterials Market Forecast (2017-2022) 15 Research Findings and Conclusion 16 Appendix Inquire more for more details about this report at: https://www.themarketreports.com/report/ask-your-query/488452 For more information, please visit https://www.themarketreports.com/report/2017-2022-global-top-countries-new-medical-materials-and-biomaterials-market-report-2033541899
Agency: European Commission | Branch: FP7 | Program: BSG-SME | Phase: SME-1 | Award Amount: 1.48M | Year: 2009
Each year in Europe there are:- 800000 hip operations costing approximately 1,942 per/implant, worth over 1.5 billion Hip implant operations are rising by approximately 15%. Currently 10% of all the prosthesis implanted are in patients under 55 years of age of which 33% of these will fail within 16 years with a further 20% of implant fitted to over 55s failing with in 20 years requiring revisional surgery costing 2.3 billion per annum. Treatment of younger patients with severe hip disease using a conventional THR presents a challenge with the rate of success being very low, (most failing within 16 years). To over come this Finsbury help develop the MoM BHR resurfacing hip with a survival rate of 93% over a conventional THR. However, studies have reported high concentrations of Co & Cr in the serum and/or urine of patients with MoM resurfacing implants. Studies have shown that increased levels of Co & Cr cause caners such as leukaemia and are linked with myocardiopathy. During the course of this project we intend to overcome these problems by developing a ceramic one ceramic or ceramic on polymer resurfacing hip. Like that of the MOM prosthesis will only cover the femoral head thus retaining all of the desirable properties associated with retaining an intact femur.
INVIBIO Ltd | Date: 2013-02-08
An upright column is packed with particles of a first material so the particles touch one another and a network of voids is defined between the particles. The network will be substantially continuous. A second material is then introduced into the column so the second material penetrates the network and fills the voids. The mixture of first and second materials is then consolidated using heat to melt the first or second material, whilst the other one of the first or second material remains in a solid state and acts as a space holder. Thereafter, the material which acts as the space holder may be removed thereby to leave a substantially continuous porous network defined by the material which was melted. It is found that, by use of the method, a substantially continuous network of the material which is melted can be formed and that the other material can readily be removed and/or is more easily removed compared to if a mixture of first and second materials was formed prior to packing in a column or mould.
Invibio Ltd | Date: 2012-03-21
A medical device comprises parts made by injection moulding and parts made by machining such that the respective parts have similar colours, measured on the L*, a*, b* scale. The parts made by injection moulding may be made in a process which involves introducing molten material comprising polymeric material such as PEEK into a mould, wherein a mould surface which contacts the molten material is at a temperature of at least 210 C. and maintaining the molten material in the mould for at least 90 seconds.
INVIBIO Ltd | Date: 2011-03-23
A titanium body (2) of a femoral nail incorporates an opening (3) leading into a hollow region (4) which defines a cavity in which electronics may be incorporated. A potting compound overlays the electronics, within the region (4). A 100 to 150 m thick cover (18) made from polyetheretherketone is arranged to overlay the opening (3) and close the hollow region (4). The cover (18) is made from flat polyetheretherketone film of suitable thickness which is heat shrunk onto a former and then machined to define the desired shape.
INVIBIO Ltd | Date: 2012-11-22
A framework for a removable, partial or complete prosthodontic device is made by machining, using a CAD/CAM technique, a disc 2, made from polyetheretherketone, to define the framework 4. Prosthetic teeth and gums can be secured to the framework to define the prosthodontic device.
INVIBIO Ltd | Date: 2012-06-21
Topographical features, such as projections or recesses, having a maximum dimension which is less than 3 m, with the features being separated by a distance which is less than 10 m are transferred to polyetheretherketone, on an industrial scale, by injection moulding relatively low viscosity PEEK, using a mould in which is arranged a master structure which carries the desired topography. The topographical features increase the water contact angle of a surface which includes them and such a modified surface has been shown to influence cell attachment and differentiation. Parts which incorporate the topographical features may be used in medical devices such as implantable medical devices for cardiology or for neuromodulation.
INVIBIO Ltd | Date: 2012-02-14
There are provided methods of producing a component incorporating a bioactive material. In one embodiment the method comprises: (a) using a screw extruder to mix a polymeric material (I) with a bioactive material (II) and melt the polymeric material (I); and (b) making a component by moulding; and wherein the polymeric material (I) is of a type which includes: (i) phenyl moieties; (ii) ketone moieties; and (iii) ether moieties. Also provided are components comprising a polymeric material and a bioactive material.
INVIBIO Ltd | Date: 2013-10-24
The invention is a prosthetic joint, for example knee joint, including a first joint component which is preferably polyetheretherketone containing barium sulphate and a second joint component which is preferably a polyolefin.